Integrated Diagnostics Licenses “Click Chemistry” From The Scripps Research Institute, Strengthening Partner Network

Press Release | 26 October 2011
Dr. Barry Sharpless, Nobel Laureate and Click Chemistry Pioneer, Joins Integrated Diagnostics as Advisor

SEATTLE — Integrated Diagnostics, an emerging leader in molecular diagnostics, today announced that it has signed a worldwide licensing agreement with The Scripps Research Institute, strengthening its growing network of partners. Under the license, the company will have access to “click chemistry,” a powerful chemical process developed by K. Barry Sharpless, Ph.D. Integrated Diagnostics concurrently announced that it has appointed Dr. Sharpless, who shared in the 2001 Nobel Prize for Chemistry, as an advisor. In a separate release, the company announced that it has used click chemistry in collaboration with the California Institute of Technology (Caltech) to create a synthetic class of diagnostic and therapeutic agents, with antibody-like properties.

[Read more…]

Caltech, Integrated Diagnostics Win $500K from Gates Foundation to Build Point-of-Care HIV Test

Caltech, Integrated Diagnostics Win $500K from Gates Foundation to Build Point-of-Care HIV Test

ProteoMonitor / GenomeWeb | 23 December 2011 | Adam Bonislawski
[subscription required]

Integrated Diagnostics Taking Aim at In Vivo Imaging, Therapeutics Markets with New PCC Reagents

ProteoMonitor / GenomeWeb | 28 October 2011 | Adam Bonislawski
[subscription required]

Integrated Diagnostics Taking Aim at In Vivo Imaging, Therapeutics Markets with New PCC Reagents